Calidi BiotherapeuticsCLDI
13F holders, Q4 2024 (December 31)33holders +13
18new positions
5sold out
1famous investor
$1.15avg. 13F price*
At the end of Q4 2024, 33 institutions reported holding Calidi Biotherapeutics Inc. (CLDI) in their 13F filings, up 13 from Q3 2024. 18 opened new positions and 5 sold out. The largest holders were Geode Capital Management, LLC ($184K), Millennium Management ($157K) and HighTower Advisors, LLC ($118K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Calidi Biotherapeutics Inc.
- CUSIP
- 320703309
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 18 | $757K |
| Exits | 5 | $103K |
All 13F filers, Q3 2024 → Q4 2024: 874,529 shares bought and 91,571 shares sold, net +782,958 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 33 holders
| Geode Capital Management, LLC | 0.00% | Add +304.0% | 160,018 | $184K |
| Millennium Management | 0.00% | New | 136,137 | $157K |
| HighTower Advisors, LLC | 0.00% | New | 102,276 | $118K |
| CPR Investments Inc. | 0.10% | Add +80.4% | 101,000 | $116K |
| Drive Wealth Management, LLC | 0.03% | New | 90,000 | $104K |
| Red Wave Investments LLC | 0.03% | Add +74.0% | 80,828 | $93K |
| Virtu Financial LLC | 0.00% | New | 73,448 | $84K |
| Vanguard Group Inc. | 0.00% | New | 61,374 | $71K |
| RS Crum Inc. | 0.01% | New | 40,463 | $47K |
| Jane Street Group, LLC | 0.00% | New | 33,437 | $38K |
| Susquehanna International Group, LLP | 0.00% | Reduce -2.3% | 23,010 | $26K |
| State Street Corp. | 0.00% | New | 22,790 | $26K |
| Delta Investment Management, LLC | 0.00% | No change | 21,023 | $24K |
| Northern Trust Corp. | 0.00% | New | 19,933 | $23K |
| Goldman Sachs Group Inc. | 0.00% | New | 17,509 | $20K |
| HRT Financial LP | 0.00% | New | 15,751 | $18K |
| Highbridge Capital Management LLC | 0.00% | Add +100.0% | 12,501 | $14K |
| Finepoint Capital LP | 0.00% | No change | 12,500 | $14K |
| Apollo Management Holdings, L.P. | 0.00% | No change | 12,500 | $14K |
| Bank of Montreal | 0.00% | New | 12,500 | $14K |
| Avidian Wealth Enterprises, LLC | 0.00% | New | 10,000 | $12K |
| Grassi Investment Management | 0.00% | New | 10,000 | $11K |
| UBS Group AG | 0.00% | Add +854.3% | 8,799 | $10K |
| Evermay Wealth Management LLC | 0.00% | No change | 6,342 | $7K |
| Royal Bank of Canada | 0.00% | New | 5,000 | $6K |
| Barrett & Company, Inc. | 0.00% | New | 3,500 | $4K |
| IFP Advisors, Inc | 0.00% | New | 3,500 | $4K |
| Morgan Stanley | 0.00% | Add +24.8% | 2,520 | $3K |
| Bank of America Corp. | 0.00% | Add +2102.1% | 1,057 | $1K |
| Tradewinds Capital Management, LLC | 0.00% | New | 1,000 | $1K |
| Osaic Holdings, Inc. | 0.00% | Add +197.6% | 753 | $865 |
| CVA Family Office, LLC | 0.00% | No change | 500 | $575 |
| BlackRock, Inc. | 0.00% | No change | 259 | $298 |
"% of holder's portfolio" is CLDI's weight in each manager's 13F, not the share of Calidi Biotherapeutics Inc. the manager owns.